methylprednisolone hemisuccinate has been researched along with Arthritis, Psoriatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chung, JH; Frohman, LP; Turbin, RE; Van Stavern, GP | 1 |
| Fernandez-Barreiro, A; Gomez-Gallego, M; Meca-Lallana, J | 1 |
2 other study(ies) available for methylprednisolone hemisuccinate and Arthritis, Psoriatic
| Article | Year |
|---|---|
Adalimumab-associated optic neuritis.
Topics: Adalimumab; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Arthritis, Rheumatoid; Humans; Immunity, Cellular; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methylprednisolone Hemisuccinate; Middle Aged; Optic Nerve; Optic Neuritis; Treatment Outcome; Tumor Necrosis Factor-alpha; Vision, Low | 2006 |
Multiple sclerosis onset during etanercept treatment.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Psoriatic; Etanercept; Female; Glucocorticoids; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Methylprednisolone Hemisuccinate; Multiple Sclerosis; Prednisolone; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2008 |